VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Pulse/Companies/Compare
Assort Health
VS
Ollin Biosciences

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

AH
Assort Health

Assort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.

2 Pulse stories
OB
Ollin Biosciences

Clinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatening eye diseases, including a VEGF/Ang2 bispecific antibody in Phase 3 for DME and wet AMD.

2 Pulse stories
Total Raised
$222M
$430M
Assort HealthOllin Biosciences
Last Valuation
$1.2B
Assort HealthOllin Biosciences
Biotech
Sector
Biotech
2023
Founded
2023
San Francisco, California
HQ
Chicago, Illinois
Private
Status
Private
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Ollin Biosciences investors
ARCH Venture PartnersTCGX (TCG Crossover)Andreessen HorowitzMubadala CapitalMonograph CapitalBlackstone Multi-Asset InvestingCommodore CapitalRA Capital Management

Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Ollin Biosciences.

@Trace_Cohen·t@nyvp.com